Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension

Free Subscription Articles published in Am J Respir Crit Care Med Retrieve available abstracts of 208 articles: HTML format

Single Articles

April 2024
1. BJORKMAN KR, Miles KG, Bellew LE, Schneider KA, et al
   Patent Ductus Arteriosus and Lung MRI Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
   Am J Respir Crit Care Med. 2024 Apr 3. doi: 10.1164/rccm.202310-1733.
   PubMed     Abstract available
   
   
   March 2024
2. HARDER E, Abtin F, Nardelli P, Brownstein A, et al
   Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning.
   Am J Respir Crit Care Med. 2024 Mar 19. doi: 10.1164/rccm.202312-2343.
   PubMed    
   
   
   
3. JAIN A, Epelbaum O
   Synchronous Pulmonary Arterial and Pulmonary Venous Thrombosis in Pancreatic Cancer.
   Am J Respir Crit Care Med. 2024;209:751-752.
   PubMed    
   
   
   
4. LILEY J, Newnham M, Bleda M, Bunclark K, et al
   Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism.
   Am J Respir Crit Care Med. 2024 Mar 12. doi: 10.1164/rccm.202307-1236.
   PubMed     Abstract available
   
   
   February 2024
5. KUDRYASHOVA TV, Jiang L, Goncharova EA
   What Is All of the Hype About? Hypusine Signaling as a Driver of Pulmonary Hypertension.
   Am J Respir Crit Care Med. 2024 Feb 27. doi: 10.1164/rccm.202401-0195.
   PubMed    
   
   
   
6. NAEIJE R, Tonelli AR
   Pulmonary Artery Wedge Pressure in the Diagnosis of Pulmonary Arterial Hypertension.
   Am J Respir Crit Care Med. 2024;209:242-244.
   PubMed    
   
   
   
7. HARDER EM, Divo MJ, Washko GR, Leopold JA, et al
   Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension.
   Am J Respir Crit Care Med. 2024;209:316-324.
   PubMed     Abstract available
   
   
   January 2024
8. RAJAGOPAL S, Yu YR
   Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
   Am J Respir Crit Care Med. 2024;209:131-133.
   PubMed    
   
   
   
9. FERRIAN S, Cao A, McCaffrey EF, Saito T, et al
   Single-Cell Imaging Maps Inflammatory Cell Subsets to Pulmonary Arterial Hypertension Vasculopathy.
   Am J Respir Crit Care Med. 2024;209:206-218.
   PubMed     Abstract available
   
   
   December 2023
10. YASUMA T, Fujimoto H, D'Alessandro-Gabazza CN, Gabazza EC, et al
    Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;208:1248.
    PubMed    
    
    
    
11. WEATHERALD J, Moutchia J, Al-Naamani N, McClelland RL, et al
    Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
    Am J Respir Crit Care Med. 2023;208:1231-1234.
    PubMed    
    
    
    September 2023
12. GUO M, Wikenheiser-Brokamp KA, Kitzmiller JA, Jiang C, et al
    Single Cell Multiomics Identifies Cells and Genetic Networks Underlying Alveolar Capillary Dysplasia.
    Am J Respir Crit Care Med. 2023;208:709-725.
    PubMed     Abstract available
    
    
    
13. NORLANDER AE, Abney M, Cephus JY, Roe CE, et al
    Prostaglandin I(2) Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;208:737-739.
    PubMed    
    
    
    
14. FARHA S, Aldred MA
    Regulating the Regulators: Epigenetic Modulation of Regulatory T-Cells in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Sep 8. doi: 10.1164/rccm.202308-1456.
    PubMed    
    
    
    August 2023
15. ROCHESTER CL, Alison JA, Carlin B, Jenkins AR, et al
    Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2023;208:e7-e26.
    PubMed     Abstract available
    
    
    
16. HAN MK
    From Conundrum to Cures, Pioneering Breakthroughs in Chronic Obstructive Pulmonary Disease Research: Introduction to an AJRCCM Special Issue.
    Am J Respir Crit Care Med. 2023;208:339-340.
    PubMed    
    
    
    
17. BRITTAIN EL, Tedford RJ, Maron BA
    Reply to: Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202307-1180.
    PubMed    
    
    
    
18. WU Y, Su X, Wang J, Zhang H, et al
    Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2023 Aug 10. doi: 10.1164/rccm.202306-1076.
    PubMed    
    
    
    
19. FORBES LM, Bull TM, Lahm T, Lawley JS, et al
    Right Ventricular Response to Acute Hypoxia among Healthy Humans.
    Am J Respir Crit Care Med. 2023;208:333-336.
    PubMed    
    
    
    July 2023
20. JOHNSON S, Sommer N, Cox-Flaherty K, Weissmann N, et al
    Pulmonary Hypertension: A Contemporary Review.
    Am J Respir Crit Care Med. 2023 Jul 14. doi: 10.1164/rccm.202302-0327.
    PubMed     Abstract available
    
    
    
21. LEIVA O, Garcia BD, Hobbs G
    Pulmonary Hypertension in Myeloproliferative Neoplasms: New Insights and Unexplored Horizons.
    Am J Respir Crit Care Med. 2023 Jul 10. doi: 10.1164/rccm.202306-1001.
    PubMed    
    
    
    June 2023
22. WEATHERALD J, Zanini U, Humbert M
    Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Jun 22. doi: 10.1164/rccm.202306-0990.
    PubMed    
    
    
    
23. MARON BA
    Introducing the Pulmonary Hypertension Thematic Series.
    Am J Respir Crit Care Med. 2023 Jun 21. doi: 10.1164/rccm.202306-1005.
    PubMed    
    
    
    
24. SONNTAG E, Akgun KM, Bag R, Rosensweig EB, et al
    Access to Medically Necessary Reproductive Care for Individuals with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202302-0230.
    PubMed    
    
    
    
25. MONTANI D, Thore P, Mignard X, Jais X, et al
    Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
    Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202210-1941.
    PubMed     Abstract available
    
    
    
26. WANG RS, Huang S, Waldo SW, Hess E, et al
    Elevated Pulmonary Arterial Compliance Is Associated with Survival in Pulmonary Hypertension: Results from a Novel Network Medicine Analysis.
    Am J Respir Crit Care Med. 2023 Jun 5. doi: 10.1164/rccm.202211-2097.
    PubMed     Abstract available
    
    
    
27. YANAGIHARA T, Tsubouchi K, Zhou Q, Chong M, et al
    Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
    Am J Respir Crit Care Med. 2023;207:1498-1514.
    PubMed     Abstract available
    
    
    May 2023
28. QUARCK R, Bogaard HJ, Delcroix M
    The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?
    Am J Respir Crit Care Med. 2023;207:1266-1268.
    PubMed    
    
    
    
29. NATHAN SD
    Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease.
    Am J Respir Crit Care Med. 2023 May 9. doi: 10.1164/rccm.202212-2342.
    PubMed     Abstract available
    
    
    
30. BRUSATORI S, Zinnato C, Busana M, Romitti F, et al
    High- versus Low-Flow Extracorporeal Respiratory Support in Experimental Hypoxemic Acute Lung Injury.
    Am J Respir Crit Care Med. 2023;207:1183-1193.
    PubMed     Abstract available
    
    
    April 2023
31. ULRICH S
    A Further Step Toward Meaningful Trial Outcomes for Patients with Pulmonary Arterial Hypertension: Minimal Important Difference in 6-minute-walk Distance.
    Am J Respir Crit Care Med. 2023;207:972-974.
    PubMed    
    
    
    
32. VANDERPOOL RR, Insel M, Kubba S, Rischard FP, et al
    The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling.
    Am J Respir Crit Care Med. 2023;207:1100-1102.
    PubMed    
    
    
    
33. MOUTCHIA J, McClelland RL, Al-Naamani N, Appleby DH, et al
    Minimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;207:1070-1079.
    PubMed     Abstract available
    
    
    
34. CORNFIELD DN, Nogee LM
    Rare to "Ubiquitinous": Alveolar Capillary Dysplasia, FOXF1, and a Sly Approach to Angiogenesis.
    Am J Respir Crit Care Med. 2023;207:969-971.
    PubMed    
    
    
    
35. PRADHAN A, Che L, Ustiyan V, Reza AA, et al
    Novel FOXF1-Stabilizing Compound TanFe Stimulates Lung Angiogenesis in Alveolar Capillary Dysplasia.
    Am J Respir Crit Care Med. 2023;207:1042-1054.
    PubMed     Abstract available
    
    
    
36. MCNAMARA PJ, Lakshminrusimha S
    Maldevelopment of the Immature Pulmonary Vasculature and Prolonged Patency of the Ductus Arteriosus: Association or Cause?
    Am J Respir Crit Care Med. 2023;207:814-816.
    PubMed    
    
    
    March 2023
37. LIN S, Frank DB
    SOX17 at the Intersection of Sex, Transcription, and Metabolism in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Mar 16. doi: 10.1164/rccm.202302-0284.
    PubMed    
    
    
    
38. OLIVEIRA SD
    Cardiopulmonary Pathogenic Networks: Unveiling the Gut-Lung Microbiome Axis in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;207:655-657.
    PubMed    
    
    
    
39. MOUTSOGLOU DM, Tatah J, Prisco SZ, Prins KW, et al
    Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.
    Am J Respir Crit Care Med. 2023;207:740-756.
    PubMed     Abstract available
    
    
    
40. SANGAM S, Sun X, Schwantes-An TH, Yegambaram M, et al
    SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics.
    Am J Respir Crit Care Med. 2023 Mar 13. doi: 10.1164/rccm.202203-0450.
    PubMed     Abstract available
    
    
    
41. 
    Erratum: Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure.
    Am J Respir Crit Care Med. 2023;207:636.
    PubMed    
    
    
    February 2023
42. VISWANATHAN G, Kirshner HF, Nazo N, Ali S, et al
    Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Feb 21. doi: 10.1164/rccm.202203-0441.
    PubMed     Abstract available
    
    
    
43. XANTHOULI P
    Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: For Real?
    Am J Respir Crit Care Med. 2023;207:238-240.
    PubMed    
    
    
    
44. GOLDBERG HJ
    Comparing the Incomparable: Identifying Common Themes Across a Diverse Landscape to Address Equity in Lung Allocation.
    Am J Respir Crit Care Med. 2023;207:236-238.
    PubMed    
    
    
    
45. HASSAN HJ, Naranjo M, Ayoub N, Housten T, et al
    Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry.
    Am J Respir Crit Care Med. 2023;207:312-322.
    PubMed     Abstract available
    
    
    
46. KOLAITIS NA, Chen H, Calabrese DR, Kumar K, et al
    The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision.
    Am J Respir Crit Care Med. 2023;207:300-311.
    PubMed     Abstract available
    
    
    January 2023
47. WANG ZH, Zhou Q
    Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy.
    Am J Respir Crit Care Med. 2023 Jan 13. doi: 10.1164/rccm.202211-2134.
    PubMed    
    
    
    
48. JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
    Reply to: Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising NKT Cell-based Therapy.
    Am J Respir Crit Care Med. 2023 Jan 13. doi: 10.1164/rccm.202212-2214.
    PubMed    
    
    
    
49. RAFFAY TM, Jensen EA
    Can Intermittent Hypoxemia Help Detect Pulmonary Hypertension in High-Risk Preemies?
    Am J Respir Crit Care Med. 2023 Jan 11. doi: 10.1164/rccm.202212-2290.
    PubMed    
    
    
    December 2022
50. DOUSCHAN P, Avian A, Foris V, Sassmann T, et al
    Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure.
    Am J Respir Crit Care Med. 2022;206:1418-1423.
    PubMed    
    
    
    November 2022
51. GENTLE SJ, Travers CP, Nakhmani A, Indic P, et al
    Intermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants.
    Am J Respir Crit Care Med. 2022 Nov 30. doi: 10.1164/rccm.202203-0580.
    PubMed     Abstract available
    
    
    
52. GENTLE SJ, Travers CP, Clark M, Carlo WA, et al
    Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Nov 15. doi: 10.1164/rccm.202203-0570.
    PubMed     Abstract available
    
    
    October 2022
53. MONTANI D, Weatherald J, Humbert M, Sitbon O, et al
    Reply to: Effect of Covid-19 Infection in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Oct 17. doi: 10.1164/rccm.202210-1889.
    PubMed    
    
    
    
54. JHA AK
    Effect of Covid-19 Infection in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Oct 17. doi: 10.1164/rccm.202209-1790.
    PubMed    
    
    
    
55. TAYLOR S, Isobe S, Cao A, Contrepois K, et al
    Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:1019-1034.
    PubMed     Abstract available
    
    
    September 2022
56. AL-QAZAZI R, Lima PDA, Prisco SZ, Potus F, et al
    Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:608-624.
    PubMed     Abstract available
    
    
    
57. BELHAJ A, Dewachter L, Hupkens E, Remmelink M, et al
    Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death-induced Lung Injury in Pigs.
    Am J Respir Crit Care Med. 2022;206:584-595.
    PubMed     Abstract available
    
    
    August 2022
58. COTTIN V, Selman M, Inoue Y, Wong AW, et al
    Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
    Am J Respir Crit Care Med. 2022;206:e7-e41.
    PubMed     Abstract available
    
    
    
59. 
    Erratum: Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
    Am J Respir Crit Care Med. 2022;206:362-363.
    PubMed    
    
    
    July 2022
60. YUAN P, Li J, Liu J, Liu H, et al
    Cognitive Dysfunction in Patients with Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jul 29. doi: 10.1164/rccm.202204-0726.
    PubMed    
    
    
    
61. WERTHEIM BM
    New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:12-13.
    PubMed    
    
    
    
62. FRECH TM, Austin ED
    Is It Still "Idiopathic"? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:8-10.
    PubMed    
    
    
    
63. JONES RJ, De Bie EMDD, Groves E, Zalewska KI, et al
    Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:81-93.
    PubMed     Abstract available
    
    
    June 2022
64. HERSI K, Elinoff JM
    Pulmonary Hypertension due to Interstitial Lung Disease: A New iNKlinig into Disease Pathobiology.
    Am J Respir Crit Care Med. 2022 Jun 30. doi: 10.1164/rccm.202206-1186.
    PubMed    
    
    
    
65. JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
    Impairment of the NKT-STAT1-CXCL9-axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Due to Lung Fibrosis.
    Am J Respir Crit Care Med. 2022 Jun 28. doi: 10.1164/rccm.202201-0142.
    PubMed     Abstract available
    
    
    
66. ABMAN SH, Mullen MP
    Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202206-1180.
    PubMed    
    
    
    
67. OKAZAKI A, Kinuya K, Fujimoto M
    Diffuse Decreased Blood Flow in the Right Lung: Mitral Regurgitation-Induced Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202110-2339.
    PubMed    
    
    
    
68. SOBRANO FAIS R, Lahm T
    Misbehaving Guests in the Right Ventricle: Macrophage NLRP3 Activation in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jun 15. doi: 10.1164/rccm.202205-0977.
    PubMed    
    
    
    
69. SIMPSON CE, Hassoun PM
    Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;205:1377-1379.
    PubMed    
    
    
    
70. HARBAUM L, Rhodes CJ, Wharton J, Lawrie A, et al
    Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;205:1449-1460.
    PubMed     Abstract available
    
    
    
71. PRZEBINDA AS, El Haj Chehade A, Farooqui SM, Youness HA, et al
    Assessment of Pulmonary Vascular Disease: Pulmonary Vascular Resistance, Exercise Hemodynamics, and Ventriculovascular Coupling.
    Am J Respir Crit Care Med. 2022;205:1349.
    PubMed    
    
    
    
72. PROVENCHER S, Potus F, Blais-Lecours P, Bernard S, et al
    BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial.
    Am J Respir Crit Care Med. 2022;205:1357-1360.
    PubMed    
    
    
    May 2022
73. LAPATRA T, Baird GL, Goodman R, Pinder D, et al
    Reply to: Remote 6-minute Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202205-0867.
    PubMed    
    
    
    
74. HELGESON SA, Burger CD, Moss JE, Zeiger TK, et al
    Remote 6-minute Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202204-0762.
    PubMed    
    
    
    
75. ALBA GA
    Double Jeopardy: Precapillary Pulmonary Hypertension Increases the Risk of Hospitalization and Death from COVID-19.
    Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202205-0884.
    PubMed    
    
    
    
76. CONSTANTINE A, Dimopoulos K, Haworth SG, Muthurangu V, et al
    Twenty-year experience and outcomes in a National Pediatric Pulmonary Hypertension Service.
    Am J Respir Crit Care Med. 2022 May 17. doi: 10.1164/rccm.202110-2428.
    PubMed     Abstract available
    
    
    
77. JIN Q, Guan L, Pan W, Zhang X, et al
    Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question.
    Am J Respir Crit Care Med. 2022;205:1250-1251.
    PubMed    
    
    
    
78. MONTANI D, Certain MC, Weatherald J, Jais X, et al
    COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
    Am J Respir Crit Care Med. 2022 May 12. doi: 10.1164/rccm.202112-2761.
    PubMed     Abstract available
    
    
    
79. RAO R, Chan SY
    A dUTY to Protect: Addressing "Y" We See Sex Differences in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 May 12. doi: 10.1164/rccm.202204-0653.
    PubMed    
    
    
    
80. CUNNINGHAM CM, Li M, Ruffenach G, Doshi M, et al
    Y-Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines.
    Am J Respir Crit Care Med. 2022 May 3. doi: 10.1164/rccm.202110-2309.
    PubMed     Abstract available
    
    
    
81. SINGH N, Ventetuolo CE
    Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?
    Am J Respir Crit Care Med. 2022;205:988-990.
    PubMed    
    
    
    
82. RHODES CJ, Wharton J, Swietlik EM, Harbaum L, et al
    Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;205:1102-1111.
    PubMed     Abstract available
    
    
    April 2022
83. TELLO K, Kremer N, Richter MJ, Gall H, et al
    Inhaled Iloprost Improves Right Ventricular Load-Independent Contractility in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Apr 15. doi: 10.1164/rccm.202201-0095.
    PubMed    
    
    
    
84. MINHAS J, Baird G, Appleby D, McClelland R, et al
    Terminal Digit Preference in Pulmonary Hypertension Endpoints.
    Am J Respir Crit Care Med. 2022 Apr 5. doi: 10.1164/rccm.202108-2015.
    PubMed    
    
    
    
85. VIZZA CD, Lang IM, Badagliacca R, Benza RL, et al
    Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
    Am J Respir Crit Care Med. 2022;205:751-760.
    PubMed     Abstract available
    
    
    February 2022
86. KOLAITIS NA, Lammi M, Mazimba S, Feldman J, et al
    Human Immune Deficiency Virus-Associated Pulmonary Arterial Hypertension: A Report from the Pulmonary Hypertension Association Registry.
    Am J Respir Crit Care Med. 2022 Feb 18. doi: 10.1164/rccm.202111-2481.
    PubMed    
    
    
    
87. SHARMA S, Lang IM
    More Evidence for Inflammatory Thrombosis in Chronic Thromboembolic Pulmonary Hypertension - Is the Embolic Hypothesis Losing Grounds?
    Am J Respir Crit Care Med. 2022 Feb 8. doi: 10.1164/rccm.202201-0001.
    PubMed    
    
    
    
88. EVRARD B, Goudelin M, Vaidie J, Fedou AL, et al
    Severe Acute Cor Pulmonale in COVID-19 ARDS Patients: Caution with Left Turn.
    Am J Respir Crit Care Med. 2022 Feb 4. doi: 10.1164/rccm.202107-1568.
    PubMed    
    
    
    January 2022
89. MANZ XD, Szulcek R, Pan X, Symersky P, et al
    Epigenetic Modification of the VWF Promotor Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 Jan 26. doi: 10.1164/rccm.202109-2075.
    PubMed     Abstract available
    
    
    
90. BEHR J
    Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally.
    Am J Respir Crit Care Med. 2022;205:144-145.
    PubMed    
    
    
    
91. LAPATRA T, Baird GL, Goodman R, Pinder D, et al
    Remote Six-Minute Walk Testing in Patients with Pulmonary Hypertension: A Pilot Study.
    Am J Respir Crit Care Med. 2022 Jan 11. doi: 10.1164/rccm.202110-2421.
    PubMed    
    
    
    
92. MOUTSOGLOU DM
    2021 American Thoracic Society BEAR Cage Winning Proposal: Microbiome Transplant in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;205:13-16.
    PubMed    
    
    
    December 2021
93. JIN Q, Guan L, Pan W, Zhou D, et al
    Initial Triple Combination Therapy for Intermediate-and High-Risk Pulmonary Arterial Hypertension: Standard of Care or Still Too Soon to Tell?
    Am J Respir Crit Care Med. 2021;204:1491-1492.
    PubMed    
    
    
    
94. RAHAGHI FN, Trieu M, Shaikh F, Abtin F, et al
    Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;204:1478-1481.
    PubMed    
    
    
    
95. DIEFFENBACH PB, Mallarino Haeger C, Rehman R, Corcoran AM, et al
    A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.
    Am J Respir Crit Care Med. 2021;204:1433-1451.
    PubMed     Abstract available
    
    
    
96. MARVIN-PEEK J, Hemnes A, Huang S, Silverman-Loyd L, et al
    Daily Step Counts Are Associated with Hospitalization Risk in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;204:1338-1340.
    PubMed    
    
    
    November 2021
97. VILLAFRANCO N, Varghese N, Sockrider M, Ely E, et al
    Pulmonary Hypertension in Children Part 1: Causes and Symptoms.
    Am J Respir Crit Care Med. 2021;204:P17-P18.
    PubMed    
    
    
    
98. NATHAN SD, Tapson VF, Elwing J, Rischard F, et al
    Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease in the INCREASE Trial.
    Am J Respir Crit Care Med. 2021 Nov 12. doi: 10.1164/rccm.202107-1766.
    PubMed     Abstract available
    
    
    
99. SUN X, Chen R, Yao X, Zheng Z, et al
    circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2021 Nov 5. doi: 10.1164/rccm.202108-1868.
    PubMed    
    
    
    
100. SUN YY, Wang L, Liu JM, Yuan P, et al
     Reply to: circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
     Am J Respir Crit Care Med. 2021 Nov 5. doi: 10.1164/rccm.202108-1905.
     PubMed    
     
     
     October 2021
101. SUN X, Chen R, Yao X, Zheng Z, et al
     Treatment of Pulmonary Hypertension: Is Triple Therapy Necessarily Better than Monotherapy?
     Am J Respir Crit Care Med. 2021 Oct 21. doi: 10.1164/rccm.202108-1965.
     PubMed    
     
     
     
102. GONCHAROVA EA, Kudryashova TV, Maroli G, Pullamsetti SS, et al
     Matrix Metalloproteinase 8 in Pulmonary Hypertension: The Sheep in the Wolf's Skin?
     Am J Respir Crit Care Med. 2021 Oct 13. doi: 10.1164/rccm.202109-2144.
     PubMed    
     
     
     
103. CASCINO TM, McLaughlin VV
     Upfront Combination Therapy for Pulmonary Arterial Hypertension: Time to Be More Ambitious than AMBITION.
     Am J Respir Crit Care Med. 2021;204:756-759.
     PubMed    
     
     
     
104. HASSOUN PM, Farber HW
     Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
     Am J Respir Crit Care Med. 2021;204:755-756.
     PubMed    
     
     
     
105. BOUCLY A, Savale L, Jais X, Bauer F, et al
     Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2021;204:842-854.
     PubMed     Abstract available
     
     
     September 2021
106. ZHENG Z, Chen R, Zhang N, Zhuang C, et al
     Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?
     Am J Respir Crit Care Med. 2021 Sep 2. doi: 10.1164/rccm.202105-1256.
     PubMed    
     
     
     
107. EUL B, Cekay M, Pullamsetti SS, Tello K, et al
     Reply to: Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?
     Am J Respir Crit Care Med. 2021 Sep 2. doi: 10.1164/rccm.202106-1411.
     PubMed    
     
     
     August 2021
108. WANG G, Wen B, Ren X, Li E, et al
     Generation of Pulmonary Endothelial Progenitor Cells for Cell-based Therapy Using Interspecies Mouse-Rat Chimeras.
     Am J Respir Crit Care Med. 2021;204:326-338.
     PubMed     Abstract available
     
     
     July 2021
109. ZHANG Y, Michelakis ED
     A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!
     Am J Respir Crit Care Med. 2021;204:123-125.
     PubMed    
     
     
     
110. ZAMANIAN RT, Badesch D, Chung L, Domsic RT, et al
     Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.
     Am J Respir Crit Care Med. 2021;204:209-221.
     PubMed     Abstract available
     
     
     June 2021
111. MARON BA, Abman SH, Elliott CG, Frantz RP, et al
     Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
     Am J Respir Crit Care Med. 2021;203:1472-1487.
     PubMed     Abstract available
     
     
     
112. YUAN P, Wu WH, Gong SG, Jiang R, et al
     Impact of circGSAP in Peripheral Blood Mononuclear Cells on Idiopathic Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2021;203:1579-1583.
     PubMed    
     
     
     
113. YAMASAKI Y, Kamitani T, Abe K, Hosokawa K, et al
     Diagnosis of Pulmonary Hypertension Using Dynamic Chest Radiography.
     Am J Respir Crit Care Med. 2021 Jun 8. doi: 10.1164/rccm.202102-0387.
     PubMed    
     
     
     April 2021
114. HONG J, Arneson D, Umar S, Ruffenach G, et al
     Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning.
     Am J Respir Crit Care Med. 2021;203:1006-1022.
     PubMed     Abstract available
     
     
     
115. MORELL E, Gaies M, Fineman JR, Charpie J, et al
     Mortality from Pulmonary Hypertension in the Pediatric Cardiac Intensive Care Unit.
     Am J Respir Crit Care Med. 2021 Apr 2. doi: 10.1164/rccm.202011-4183.
     PubMed     Abstract available
     
     
     March 2021
116. FORBES LM, Gu S, Badesch DB
     Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer.
     Am J Respir Crit Care Med. 2021 Mar 31. doi: 10.1164/rccm.202103-0740.
     PubMed    
     
     
     
117. WANG J, Yang K, Yuan JX
     NEDD9, a Hypoxia-upregulated Mediator for Pathogenic Platelet-endothelial Cell Interaction in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2021 Mar 26. doi: 10.1164/rccm.202101-0007.
     PubMed    
     
     
     
118. SOCKRIDER M, Roessel L, Fagan KA, Gillespie M, et al
     Diagnosis and Treatment of Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2021;203:P14-P15.
     PubMed    
     
     
     
119. VIELE K, Girard TD
     Risk, Results, and Costs: Optimizing Clinical Trial Efficiency through Prognostic Enrichment.
     Am J Respir Crit Care Med. 2021;203:671-672.
     PubMed    
     
     
     
120. HUMBERT M, Lau EMT
     Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
     Am J Respir Crit Care Med. 2021;203:675-677.
     PubMed    
     
     
     
121. SCOTT JV, Garnett CE, Kanwar MK, Stockbridge NL, et al
     Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials.
     Am J Respir Crit Care Med. 2021;203:726-736.
     PubMed     Abstract available
     
     
     
122. SOCKRIDER M
     What Is Pulmonary Hypertension?
     Am J Respir Crit Care Med. 2021;203:P12-P13.
     PubMed    
     
     
     
123. AGARWAL S, de Jesus Perez VA
     In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2021;203:541-542.
     PubMed    
     
     
     
124. VITRY G, Paulin R, Grobs Y, Lampron MC, et al
     Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2021;203:614-627.
     PubMed     Abstract available
     
     
     February 2021
125. BONNET S, Gomez D
     RNA Methylation: A New Regulator of Vascular Remodeling in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2021 Feb 26. doi: 10.1164/rccm.202011-4185.
     PubMed    
     
     
     
126. BADAGLIACCA R, D'Alto M, Ghio S, Vizza CD, et al
     Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Piece de Resistance?
     Am J Respir Crit Care Med. 2021;203:525-526.
     PubMed    
     
     
     
127. WEATHERALD J, Boucly A, Savale L, Jais X, et al
     Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Piece de Resistance?
     Am J Respir Crit Care Med. 2021;203:524-525.
     PubMed    
     
     
     
128. SCHOENBERG NC, Farber HW
     When "AMBITION" Isn't Good Enough: Risk Status and Dual Oral Therapy in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2021;203:410-411.
     PubMed    
     
     
     
129. KHURAL JS, Houston BA, Leary PJ, Mathai SC, et al
     Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2021;203:508-511.
     PubMed    
     
     
     
130. BADAGLIACCA R, D'Alto M, Ghio S, Argiento P, et al
     Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2021;203:484-492.
     PubMed     Abstract available
     
     
     
131. KARNES JH, Schwantes-An TH, Kittles R, Desai AA, et al
     Reply to Non and Chang: Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities.
     Am J Respir Crit Care Med. 2021;203:398-399.
     PubMed    
     
     
     
132. NON AL, Chang SY
     Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities.
     Am J Respir Crit Care Med. 2021;203:397-398.
     PubMed    
     
     
     
133. HIRAIDE T, Teratani T, Uemura S, Yoshimatsu Y, et al
     Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting against Colitis.
     Am J Respir Crit Care Med. 2021;203:385-388.
     PubMed    
     
     
     January 2021
134. HU L, Wang J, Huang H, Yu Y, et al
     YTHDF1 Regulates Pulmonary Hypertension Through Translational Control of MAGED1.
     Am J Respir Crit Care Med. 2021 Jan 19. doi: 10.1164/rccm.202009-3419.
     PubMed     Abstract available
     
     
     
135. RODRIGUEZ-LOPEZ J, Wright CD, Stone JR, Farber H, et al
     When Imaging in Chronic Thromboembolic Pulmonary Hypertension Is Not Enough.
     Am J Respir Crit Care Med. 2021;203:e3-e4.
     PubMed    
     
     
     
136. SYNN AJ, Li W, San Jose Estepar R, Washko GR, et al
     Pulmonary Vascular Pruning on Computed Tomography and Risk of Death in the Framingham Heart Study.
     Am J Respir Crit Care Med. 2021;203:251-254.
     PubMed    
     
     
     
137. EUL B, Cekay M, Pullamsetti SS, Tello K, et al
     Non-invasive Surrogate Markers of PH are Associated with Poor Survival in Lung Cancer Patients.
     Am J Respir Crit Care Med. 2021 Jan 7. doi: 10.1164/rccm.202005-2023.
     PubMed    
     
     
     December 2020
138. HUANG SK
     Knocking Out Smoking and Pulmonary Hypertension with a K().
     Am J Respir Crit Care Med. 2020 Dec 23. doi: 10.1164/rccm.202011-4121.
     PubMed    
     
     
     
139. ALDRED MA
     PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?
     Am J Respir Crit Care Med. 2020;202:1500-1502.
     PubMed    
     
     
     
140. AMIN EK, Austin ED, Parker C, Colglazier E, et al
     Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales?
     Am J Respir Crit Care Med. 2020;202:1587-1589.
     PubMed    
     
     
     November 2020
141. MIN J, Badesch D, Chakinala M, Elwing J, et al
     Prediction of Health-Related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).
     Am J Respir Crit Care Med. 2020 Nov 19. doi: 10.1164/rccm.202010-3967.
     PubMed    
     
     
     
142. CHELLADURAI P, Savai R, Pullamsetti SS
     Zooming into Cellular and Molecular Heterogeneity of Pulmonary Hypertension: What More Single-cell Omics Can Offer.
     Am J Respir Crit Care Med. 2020 Nov 10. doi: 10.1164/rccm.202010-3889.
     PubMed    
     
     
     
143. MISNER K, Kass DJ
     A Plot TWIST in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;202:1214-1216.
     PubMed    
     
     
     October 2020
144. THENAPPAN T, Weir EK
     Pulmonary Arterial Hypertension and Sex in the Right Ventricle: It Is an Interesting Picture!
     Am J Respir Crit Care Med. 2020;202:928-929.
     PubMed    
     
     
     
145. TELLO K, Richter MJ, Yogeswaran A, Ghofrani HA, et al
     Sex Differences in Right Ventricular-Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;202:1042-1046.
     PubMed    
     
     
     September 2020
146. L'HEUREUX M, Swiatek K, Guthrie R, Brath L, et al
     Pulmonary Hypertension: Advances in Risk Assessment and Emerging Procedures.
     Am J Respir Crit Care Med. 2020;202:745-747.
     PubMed    
     
     
     August 2020
147. MARON BA
     Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics.
     Am J Respir Crit Care Med. 2020;202:488-490.
     PubMed    
     
     
     
148. RHODES CJ, Otero-Nunez P, Wharton J, Swietlik EM, et al
     Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome.
     Am J Respir Crit Care Med. 2020;202:586-594.
     PubMed     Abstract available
     
     
     July 2020
149. HAFEEZ N, Chan SY
     A New "TYK" Tok Era for the Study of Long Non-Coding RNAs in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2020 Jul 29. doi: 10.1164/rccm.202007-2632.
     PubMed    
     
     
     
150. FAN Y, Gu X, Zhang J, Sinn K, et al
     TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2.
     Am J Respir Crit Care Med. 2020 Jul 21. doi: 10.1164/rccm.201909-1884.
     PubMed     Abstract available
     
     
     
151. RUOPP NF, Farber HW
     The Elephant Man Meets Pulmonary Hypertension: A Cautionary Tale.
     Am J Respir Crit Care Med. 2020 Jul 15. doi: 10.1164/rccm.202006-2142.
     PubMed    
     
     
     
152. BOTROS L, Szulcek R, Jansen SMA, Kurakula K, et al
     The Effects of Mercaptopurine on Pulmonary Vascular Resistance and BMPR2 Expression in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;202:296-299.
     PubMed    
     
     
     
153. ZEHENDNER CM, Valasarajan C, Werner A, Boeckel JN, et al
     Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-Mediated Regulation of PDGFRbeta.
     Am J Respir Crit Care Med. 2020 Jul 7. doi: 10.1164/rccm.201910-2041.
     PubMed     Abstract available
     
     
     
154. GONCHAROVA EA, Chan SY, Ventetuolo CE, Weissmann N, et al
     Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.
     Am J Respir Crit Care Med. 2020;202:22-28.
     PubMed    
     
     
     June 2020
155. ROCHON ER, Krowka MJ, Bartolome S, Heresi GA, et al
     BMP9/10 in Pulmonary Vascular Complications of Liver Disease.
     Am J Respir Crit Care Med. 2020;201:1575-1578.
     PubMed    
     
     
     
156. AUSTIN ED, Hamid R
     Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;201:1329-1331.
     PubMed    
     
     
     
157. KARNES JH, Wiener HW, Schwantes-An TH, Natarajan B, et al
     Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;201:1407-1415.
     PubMed     Abstract available
     
     
     May 2020
158. JUTANT EM, Jais X, Girerd B, Savale L, et al
     Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
     Am J Respir Crit Care Med. 2020 May 21. doi: 10.1164/rccm.202001-0105.
     PubMed     Abstract available
     
     
     
159. ALVAREZ RA, Berra L, Gladwin MT
     Home NO Therapy for COVID-19.
     Am J Respir Crit Care Med. 2020 May 21. doi: 10.1164/rccm.202005-1906.
     PubMed    
     
     
     
160. MONTANI D, Jais X, Humbert M, Sitbon O, et al
     Pulmonary Hypertension Complicating Pulmonary Artery Involvement in Pseudoxanthoma Elasticum.
     Am J Respir Crit Care Med. 2020 May 15. doi: 10.1164/rccm.202002-0248.
     PubMed    
     
     
     
161. GONCHAROVA EA, Simon MA, Yuan JX
     mTORC1 in Pulmonary Arterial Hypertension. At the Crossroads between Vasoconstriction and Vascular Remodeling?
     Am J Respir Crit Care Med. 2020;201:1177-1179.
     PubMed    
     
     
     
162. HE Y, Zuo C, Jia D, Bai P, et al
     Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
     Am J Respir Crit Care Med. 2020;201:1263-1276.
     PubMed     Abstract available
     
     
     
163. ZAMANIAN RT, Pollack CV Jr, Gentile MA, Rashid M, et al
     Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive IPAH and COVID-19 Infection.
     Am J Respir Crit Care Med. 2020 May 5. doi: 10.1164/rccm.202004-0937.
     PubMed    
     
     
     
164. PLOSA EJ, Benjamin JT
     rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia Prevention?
     Am J Respir Crit Care Med. 2020;201:1032-1033.
     PubMed    
     
     
     April 2020
165. CROUSER ED, Maier LA, Wilson KC, Bonham CA, et al
     Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.
     Am J Respir Crit Care Med. 2020;201:e26-e51.
     PubMed     Abstract available
     
     
     March 2020
166. HILL NS, Farber HW, Preston IR
     An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail.
     Am J Respir Crit Care Med. 2020;201:647-649.
     PubMed    
     
     
     
167. WHITE RJ, Jerjes-Sanchez C, Bohns Meyer GM, Pulido T, et al
     Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
     Am J Respir Crit Care Med. 2020;201:707-717.
     PubMed     Abstract available
     
     
     
168. MULCHRONE A, Bellofiore A, Douwes JM, Duong N, et al
     Impaired Right Ventricular-Vascular Coupling in Young Adults Born Preterm.
     Am J Respir Crit Care Med. 2020;201:615-618.
     PubMed    
     
     
     
169. MASA JF, Mokhlesi B, Benitez I, Mogollon MV, et al
     Echocardiographic Changes with Positive Airway Pressure Therapy in Obesity Hypoventilation Syndrome. Long-Term Pickwick Randomized Controlled Clinical Trial.
     Am J Respir Crit Care Med. 2020;201:586-597.
     PubMed     Abstract available
     
     
     
170. HODGSON J, Swietlik EM, Salmon RM, Hadinnapola C, et al
     Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;201:575-585.
     PubMed     Abstract available
     
     
     February 2020
171. SEEDORF G, Kim C, Wallace B, Mandell EW, et al
     rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental BPD.
     Am J Respir Crit Care Med. 2020 Feb 26. doi: 10.1164/rccm.201910-1975.
     PubMed     Abstract available
     
     
     
172. RICHTER MJ, Tello K
     Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;201:403-405.
     PubMed    
     
     
     
173. LEWIS RA, Johns CS, Cogliano M, Capener D, et al
     Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;201:458-468.
     PubMed     Abstract available
     
     
     
174. CHEN L, Liu C, Lu W, Wang T, et al
     BET Signaling, A Novel Therapeutic Target for Pulmonary Hypertension?
     Am J Respir Crit Care Med. 2020 Feb 7. doi: 10.1164/rccm.201912-2525.
     PubMed    
     
     
     
175. PROVENCHER S, Boucherat O, Berger RMF, Goumans MJ, et al
     Reply to: BET Signaling, A Novel Therapeutic Target for Pulmonary Hypertension?
     Am J Respir Crit Care Med. 2020 Feb 7. doi: 10.1164/rccm.202001-0059.
     PubMed    
     
     
     
176. NING D, Du J, Yang XQ, Wang DX, et al
     More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;201:388-389.
     PubMed    
     
     
     
177. PROVENCHER S, Boucherat O, Berger RMF, Goumans MJ, et al
     Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;201:389-391.
     PubMed    
     
     
     January 2020
178. NICKEL NP, Yuan K, Dorfmuller P, Provencher S, et al
     Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2020;201:148-157.
     PubMed     Abstract available
     
     
     
179. HON S, Channick RN, Farber HW
     Unilateral Chronic Thromboembolic Pulmonary Disease: A Mimic of Pulmonary Artery Agenesis.
     Am J Respir Crit Care Med. 2020 Jan 3. doi: 10.1164/rccm.201905-0997.
     PubMed    
     
     
     
180. HASSOUN PM
     Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia.
     Am J Respir Crit Care Med. 2020;201:7-9.
     PubMed    
     
     
     
181. PARK JB, Suh M, Park JY, Park JK, et al
     Assessment of Inflammation in Pulmonary Artery Hypertension by (68)Ga-Mannosylated Human Serum Albumin.
     Am J Respir Crit Care Med. 2020;201:95-106.
     PubMed     Abstract available
     
     
     November 2019
182. BOGAARD HJ, Legchenko E, Ackermann M, Kuhnel MP, et al
     Reply to: Early Disruption of VEGF Receptor Signalling and the Risk for Adult Emphysema.
     Am J Respir Crit Care Med. 2019 Nov 26. doi: 10.1164/rccm.201910-1983.
     PubMed    
     
     
     
183. LE CRAS TD, Abman SH
     Early Disruption of VEGF Receptor Signaling and the Risk for Adult Emphysema.
     Am J Respir Crit Care Med. 2019 Nov 26. doi: 10.1164/rccm.201909-1698.
     PubMed    
     
     
     
184. HAARMAN MG, Douwes JM, Ploegstra MJ, Roofthooft MTR, et al
     The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019;200:1312-1315.
     PubMed    
     
     
     
185. AL-NAAMANI N, Ventetuolo CE
     Another Piece in the Estrogen Puzzle of Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2019 Nov 5. doi: 10.1164/rccm.201910-1982.
     PubMed    
     
     
     
186. PIQUEREAU J, Perros F
     BET Bromodomain Inhibitors and Pulmonary Arterial Hypertension: Take Care of the Heart.
     Am J Respir Crit Care Med. 2019;200:1187-1188.
     PubMed    
     
     
     
187. PULLAMSETTI SS, de Jesus Perez VA
     EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.
     Am J Respir Crit Care Med. 2019;200:1188-1190.
     PubMed    
     
     
     
188. KURAKULA K, Boucherat O, Van der Feen DE, Bogaard HJ, et al
     Reply to Piquereau and Perros and to Pullamsetti and de Jesus Perez.
     Am J Respir Crit Care Med. 2019;200:1190-1191.
     PubMed    
     
     
     October 2019
189. PHILIP JL, Tabima DM, Wolf GD, Frump AL, et al
     Exogenous Estrogen Preserves Distal Pulmonary Arterial Mechanics and Prevents Pulmonary Hypertension in Rats.
     Am J Respir Crit Care Med. 2019 Oct 29. doi: 10.1164/rccm.201906-1217.
     PubMed    
     
     
     
190. WAMBACH JA, Nogee LM
     A Step toward Treating a Lethal Neonatal Lung Disease. STAT3 and Alveolar Capillary Dysplasia.
     Am J Respir Crit Care Med. 2019;200:961-962.
     PubMed    
     
     
     
191. PRADHAN A, Dunn A, Ustiyan V, Bolte C, et al
     The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia.
     Am J Respir Crit Care Med. 2019;200:1045-1056.
     PubMed     Abstract available
     
     
     
192. GRUNIG G, Durmus N
     An Emotional Molecular Pathway in Pulmonary Hypertension - Alternative Complement System.
     Am J Respir Crit Care Med. 2019 Oct 10. doi: 10.1164/rccm.201909-1790.
     PubMed    
     
     
     
193. DAI Z, Zhao YY
     BET in Pulmonary Arterial Hypertension: Exploration of BET Inhibitors to Reverse Vascular Remodeling.
     Am J Respir Crit Care Med. 2019;200:806-808.
     PubMed    
     
     
     
194. VAN DER FEEN DE, Kurakula K, Tremblay E, Boucherat O, et al
     Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019;200:910-920.
     PubMed     Abstract available
     
     
     September 2019
195. KOVACS L, Cao Y, Han W, Meadows L, et al
     PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019;200:617-627.
     PubMed     Abstract available
     
     
     August 2019
196. BOGAARD HJ, Legchenko E, Chaudhary KR, Sun X, et al
     Emphysema is - at the most - only a Mild Phenotype in the Sugen-Hypoxia Rat Model of Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019 Aug 22. doi: 10.1164/rccm.201906-1200.
     PubMed    
     
     
     
197. KOJONAZAROV B, Hadzic S, Ghofrani HA, Grimminger F, et al
     Reply to: Emphysema is - at the most - only a Mild Phenotype in the Sugen-Hypoxia Rat Model of Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019 Aug 22. doi: 10.1164/rccm.201907-1367.
     PubMed    
     
     
     June 2019
198. GRINNAN D, Farkas L
     A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019;199:1460-1461.
     PubMed    
     
     
     
199. GOLDENBERG NM, Hu Y, Hu X, Volchuk A, et al
     Therapeutic Targeting of High-Mobility Group Box-1 in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019;199:1566-1569.
     PubMed    
     
     
     
200. KOHLI P, Kelly VJ, Kehl EG, Rodriguez-Lopez J, et al
     Perfusion Imaging Distinguishes Exercise Pulmonary Arterial Hypertension at Rest.
     Am J Respir Crit Care Med. 2019;199:1438-1441.
     PubMed    
     
     
     
201. TELLO K, Dalmer A, Husain-Syed F, Seeger W, et al
     Multibeat Right Ventricular-Arterial Coupling during a Positive Acute Vasoreactivity Test.
     Am J Respir Crit Care Med. 2019;199:e41-e42.
     PubMed    
     
     
     
202. SAWADA H, Mitani Y, Nakayama T, Fukushima H, et al
     Detection of Pediatric Pulmonary Arterial Hypertension by School Electrocardiography Mass Screening.
     Am J Respir Crit Care Med. 2019;199:1397-1406.
     PubMed     Abstract available
     
     
     May 2019
203. RUIGROK D, Meijboom LJ, Westerhof BE, In 't Veld AH, et al
     Right Ventricular Load and Function in Chronic Thromboembolic Pulmonary Hypertension: Differences between Proximal and Distal Chronic Thromboembolic Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2019;199:1163-1166.
     PubMed    
     
     
     April 2019
204. NIKOLIC I, Yung LM, Yang P, Malhotra R, et al
     Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.
     Am J Respir Crit Care Med. 2019;199:891-902.
     PubMed     Abstract available
     
     
     March 2019
205. TANGUAY VF, Babin C, Giardetti G, Sohier-Poirier C, et al
     Enhanced Pulmonary Artery Radiodensity in Pulmonary Arterial Hypertension: A Sign of Early Calcification?
     Am J Respir Crit Care Med. 2019;199:799-802.
     PubMed    
     
     
     February 2019
206. TRANKLE CR, Canada JM, Kadariya D, Markley R, et al
     IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.
     Am J Respir Crit Care Med. 2019;199:381-384.
     PubMed    
     
     
     January 2019
207. GRAHAM BB, Yu PB
     Finding the Target: In Silico and Genetic Screening for Mechanistically Novel Drugs in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019;199:9-11.
     PubMed    
     
     
     
208. DANNEWITZ PROSSEDA S, Tian X, Kuramoto K, Boehm M, et al
     FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2019;199:83-98.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.